ApoER2 expression increases Aβ production while decreasing Amyloid Precursor Protein (APP) endocytosis: Possible role in the partitioning of APP into lipid rafts and in the regulation of γ-secretase activity-4 by Rodrigo A Fuentealba (77901)

Subjects:

ApoER2 expression increases Aβ production while decreasing Amyloid Precursor Protein (APP) endocytosis: Possible role in the partitioning of APP into lipid rafts and in the regulation of γ-secretase activity-2 by Rodrigo A Fuentealba (77901)

Subjects:

ApoER2 expression increases Aβ production while decreasing Amyloid Precursor Protein (APP) endocytosis: Possible role in the partitioning of APP into lipid rafts and in the regulation of γ-secretase activity-7 by Rodrigo A Fuentealba (77901)

Subjects:

ApoER2 expression increases Aβ production while decreasing Amyloid Precursor Protein (APP) endocytosis: Possible role in the partitioning of APP into lipid rafts and in the regulation of γ-secretase activity-5 by Rodrigo A Fuentealba (77901)

Subjects:

ApoER2 expression increases Aβ production while decreasing Amyloid Precursor Protein (APP) endocytosis: Possible role in the partitioning of APP into lipid rafts and in the regulation of γ-secretase activity-9 by Rodrigo A Fuentealba (77901)

Subjects:

ApoER2 expression increases Aβ production while decreasing Amyloid Precursor Protein (APP) endocytosis: Possible role in the partitioning of APP into lipid rafts and in the regulation of γ-secretase activity-10 by Rodrigo A Fuentealba (77901)

Subjects:

ApoER2 expression increases Aβ production while decreasing Amyloid Precursor Protein (APP) endocytosis: Possible role in the partitioning of APP into lipid rafts and in the regulation of γ-secretase activity-0 by Rodrigo A Fuentealba (77901)

Subjects:

Results of linear mixed effects models on incubation time, hatchling body mass and growth parameters, growth rate constant (K), asymptotic body mass (A) and inflection point (I) ca... by Henrik H. Berntsen (11767710)

Sign of regression effects predicted by a hypothesis of a true increasing or decreasing effect and a hypothesis of spurious associations. by Kimmo Sorjonen (495847)

“…<p>Sign of regression effects predicted by a hypothesis of a true increasing or decreasing effect and a hypothesis of spurious associations.…”

Decreased deaminase activity in A12-infected cells despite a high level of A3B protein. by Noémie Lejeune (9243785)

VACV sA28 and sH2 <i>in vitro</i> protein binding analyses. by Chi-Fei Kao (11414234)

“…The black dashed line in D marked 40% intensity decrease. (<b>E</b>) Ribbon representation of the NMR-derived molecular structure of tA28, with the most perturbed regions I, II and III highlighted in the respective colors shown in (C).…”

Aggrecan knockdown ATDC5 chondroprogenitor cells have decreased Alcian blue staining and absorbance levels compared to control cells after ITS stimulation. by Juanita K. Hodax (6848540)

Blocking CD88 decreased ANCA antigen translocation, ANCA-induced respiratory burst and degranulation in C5a-primed neutrophils. by Jian Hao (160736)

“…C and D: blocking CD88 decreased C5a-primed neutrophils for ANCA-induced respiratory burst. …”

GSK360A increased kidney EPO and brain VEGF mRNA after stroke. by Jin Zhou (90734)

Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”

Effect of GSK360A on APA learning performance 3 weeks after tMCAO stroke. by Jin Zhou (90734)

Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”

The blood plasma, kidney, and brain concentration levels (ng/ml) of GSK360A presented for 5 and 24 hours after GSK360A (30 mg/kg) was administered orally by gavage. by Jin Zhou (90734)

Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”

Body weight was measured over the course of the study. by Jin Zhou (90734)

Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”

TTC staining of forebrain 2 mm thick sections conducted 4 weeks after tMCAO stroke (1 week after APA testing). by Jin Zhou (90734)

Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”

Overall schematic of basic experimental studies and designs. by Jin Zhou (90734)

Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”

The chemical structure and the enzymatic and cellular activity of GSK360A. by Jin Zhou (90734)

Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”